ADR programme
Generic Crestor Wins Approval, Dealing a Blow to AstraZeneca - The New York Times
AstraZeneca wins EU backing for heart drug, but suffers lung cancer setback | Reuters
About Our Company - AstraZeneca
Understanding hesitancy with revealed preferences across COVID-19 vaccine types | Scientific Reports
Transforming AstraZeneca's R&D productivity
AstraZeneca | Business | The Guardian
AstraZeneca, U.S. agree 500,000 more supplies of COVID-19 antibody cocktail | Reuters
U.S. FDA approves AstraZeneca's lung cancer drugs | Reuters
FDA pulls authorization for AstraZeneca's Covid antibody drug Evusheld
Ethics and transparency - Our Company - AstraZeneca
Externally Sponsored Scientific Research - AstraZeneca
AstraZeneca - Research-Based BioPharmaceutical Company
Annual report 2022
AstraZeneca US
AstraZeneca US
Partnering
How the Oxford-AstraZeneca Covid-19 Vaccine Works - The New York Times
AstraZeneca to pay $425 million to settle lawsuits over heartburn drugs | The Hill
Ethics and transparency - Our Company - AstraZeneca
Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework | Nature Reviews Drug Discovery
Coronavirus (COVID-19) information & research hub | AstraZeneca
Annual Reports
AstraZeneca launches Evinova to bring AI to clinical trials | MobiHealthNews
